Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma

International Journal of Biochemistry and Cell Biology

Volumn 53, Issue , 2014, Pages 208-217

  Wojcicka, Anna ^a,c   Swierniak, Michal ^a,b   Kornasiewicz, Oskar ^a   Gierlikowski, Wojciech ^a   Maciag, Monika ^a   Kolanowska, Monika ^a   Kotlarek, Marta ^a   Gornicka, Barbara ^a   Koperski, Lukasz ^a   Niewinski, Grzegorz ^a   Krawczyk, Marek ^a   Jazdzewski, Krystian ^a,c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Deep sequencing; HCC; Isoforms; Liver cancer; miRs

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 122; MICRORNA 199A 3P; MICRORNA 199A 5P; MICRORNA 199B 3P; MICRORNA 214 5P; MICRORNA 490 3P; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ISOPROTEIN; TRANSCRIPTOME;

ARTICLE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN GENOME; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLECULAR RECOGNITION; NEXT GENERATION SEQUENCING; REGULATORY MECHANISM; RNA ANALYSIS; RNA BINDING; RNA SEQUENCE; STUDENT T TEST; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; LIVER TUMOR; PATHOLOGY;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICRORNAS; PROTEIN ISOFORMS; TRANSCRIPTOME;

EID: 84902491924     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.05.020     Document Type: Article

References (46)

1. D.P. Bartel MicroRNAs: Target Recognition and Regulatory Functions Cell 136 2009 215 233
2. J. Bruix, L. Boix, M. Sala, and J.M. Llovet Focus on hepatocellular carcinoma Cancer Cell 5 2004 215
3. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
4. D.F. Calvisi, M. Frau, M.L. Tomasi, F. Feo, and R.M. Pascale Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison Biochim Biophys Acta 1826 2012 215 237
5. H.R. Chiang, L.W. Schoenfeld, J.G. Ruby, V.C. Auyeung, N. Spies, and D. Baek et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes Genes Dev 24 2010 992 1009
6. Y. Choi, H.P. Dienes, and K. Krawczynski Kinetics of miR-122 expression in the liver during acute HCV infection PLoS One 8 2013 e76501
7. N. Cloonan, S. Wani, Q. Xu, J. Gu, K. Lea, and S. Heater et al. MicroRNAs and their isomiRs function cooperatively to target common biological pathways Genome Biol 12 2012 R126
8. G. Diaz, M. Melis, A. Tice, D.E. Kleiner, L. Mishra, and F. Zamboni et al. Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma Int J Cancer 133 2013 816 824
9. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 2008 102 114
10. L. Gramantieri, M. Ferracin, F. Fornari, A. Veronese, S. Sabbioni, and C.G. Liu et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res 67 2007 6092 6099
11. S. Griffiths-Jones miRBase: the microRNA sequence database Methods Mol Biol 342 2006 129 138
12. A.E. Hoffman, T. Zheng, C. Yi, D. Leaderer, J. Weidhaas, and F. Slack et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis Cancer Res 69 2009 5970 5977
13. E. Hornstein, J.H. Mansfield, S. Yekta, J.K. Hu, B.D. Harfe, and M.T. McManus et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development Nature 438 2005 671 674
14. J. Hou, L. Lin, W. Zhou, Z. Wang, G. Ding, and Q. Dong et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma Cancer Cell 19 2011 232 243
15. Z. Hu, J. Chen, T. Tian, X. Zhou, H. Gu, and L. Xu et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival J Clin Invest 118 2008 2600 2608
16. D.T. Humphreys, C.J. Hynes, H.R. Patel, G.H. Wei, L. Cannon, and D. Fatkin et al. Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function PLoS One 7 2012 e30933
17. S.P. Hussain, J. Schwank, F. Staib, X.W. Wang, and C.C. Harris TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer Oncogene 26 2007 2166 2176
18. K. Jazdzewski, J. Boguslawska, J. Jendrzejewski, S. Liyanarachchi, J. Pachucki, and K.A. Wardyn et al. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC) J Clin Endocrinol Metab 96 2011 E546 E553
19. K. Jazdzewski, and A. de la Chapelle Genomic sequence matters: a SNP in microRNA-146a can turn anti-apoptotic Cell Cycle 8 2009 1642 1643
20. K. Jazdzewski, S. Liyanarachchi, M. Swierniak, J. Pachucki, M.D. Ringel, and B. Jarzab et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer Proc Natl Acad Sci USA 106 2009 1502 1505
21. K. Jazdzewski, E.L. Murray, K. Franssila, B. Jarzab, D.R. Schoenberg, and A. de la Chapelle Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proc Natl Acad Sci USA 105 2008 7269 7274
22. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
23. E. Kozlowska, W.J. Krzyzosiak, and E. Koscianska Regulation of huntingtin gene expression by miRNA-137, -214-148a, and their respective isomiRs Int J Mol Sci 14 2013 16999 17016
24. A. Kozomara, and S. Griffiths-Jones miRBase: integrating microRNA annotation and deep-sequencing data Nucleic Acids Res 39 2011 D152 D157
25. J. Kozubek, Z. Ma, E. Fleming, T. Duggan, R. Wu, and D.G. Shin et al. In-depth characterization of microRNA transcriptome in melanoma PLoS One 8 2013 e72699
26. F. Kuchenbauer, R.D. Morin, B. Argiropoulos, O.I. Petriv, M. Griffith, and M. Heuser et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model Genome Res 18 2008 1787 1797
27. P. Landgraf, M. Rusu, R. Sheridan, A. Sewer, N. Iovino, and A. Aravin et al. A mammalian microRNA expression atlas based on small RNA library sequencing Cell 129 2007 1401 1414
28. B. Langmead, C. Trapnell, M. Pop, and S.L. Salzberg Ultrafast and memory-efficient alignment of short DNA sequences to the human genome Genome Biol 10 2009 R25
29. P.T. Law, H. Qin, A.K. Ching, K.P. Lai, N.N. Co, and M. He et al. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma J Hepatol 58 2013 1165 1173
30. S. Li, X. Xing, Q. Yang, H. Xu, J. He, and Z. Chen et al. The effects of hepatitis C virus core protein on the expression of miR-122 in vitro Virol J 10 2013 98
31. X.D. Li, Z.G. Li, X.X. Song, and C.F. Liu A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis Pathology 42 2010 669 673
32. L.P. Lim, N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, and J. Castle et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature 433 2005 769
33. F. Llorens, M. Hummel, L. Pantano, X. Pastor, A. Vivancos, and E. Castillo et al. Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factor BMC Genomics 14 2013 371
34. R. Luthra, R.R. Singh, M.G. Luthra, Y.X. Li, C. Hannah, and A.M. Romans et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers Oncogene 27 2008 6667 6678
35. M.M. Martin Cutadapt removes adaptor sequences from high-throughput sequencing reads EMBnetjournal 2011 17
36. R.D. Morin, M.D. O'Connor, M. Griffith, F. Kuchenbauer, A. Delaney, and A.-L. Prabhu et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells Genome Res 18 2008 610 621
37. M. Negrini, L. Gramantieri, S. Sabbioni, and C.M. Croce microRNA involvement in hepatocellular carcinoma Anticancer Agents Med Chem 11 2011 500 521
38. C.B. Nielsen, N. Shomron, R. Sandberg, E. Hornstein, J. Kitzman, and C.B. Burge Determinants of targeting by endogenous and exogenous microRNAs and siRNAs RNA 13 2007 1894 1910
39. P. Qi, T.H. Dou, L. Geng, F.G. Zhou, X. Gu, and H. Wang et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection Hum Immunol 71 2010 621 626
40. J. Starega-Roslan, J. Krol, E. Koscianska, P. Kozlowski, W.J. Szlachcic, and K. Sobczak et al. Structural basis of microRNA length variety Nucleic Acids Res 39 2011 257 268
41. M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, and W. Wiechno et al. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma J Clin Endocrinol Metab 98 2013 E1401 E1409
42. M.L. Tornesello, L. Buonaguro, F. Tatangelo, G. Botti, F. Izzo, and F.M. Buonaguro Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections Genomics 102 2013 74 83
43. W.C. Tsai, P.W. Hsu, T.C. Lai, G.Y. Chau, C.W. Lin, and C.M. Chen et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma Hepatology 49 2009 1571 1582
44. S. Wang, L. Qiu, X. Yan, W. Jin, Y. Wang, and L. Chen et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity Hepatology 55 2012 730 741
45. A. Wojcicka, A. de la Chapelle, and K. Jazdzewski MicroRNA-related sequence variations in human cancers Hum Genet 133 2014 463 469
46. T. Xu, Y. Zhu, Q.K. Wei, Y. Yuan, F. Zhou, and Y.Y. Ge et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma Carcinogenesis 29 2008 2126 2131